Conceptio
›
diabetic-nephropathy
Topic
diabetic-nephropathy
Knowledge-graph topic
· documents ABOUT diabetic-nephropathy across the archive
77
Documents about diabetic-nephropathy
Documents about diabetic-nephropathy
Study Of Diabetic Nephropathy With Atrasentan
#245440
ClinicalTrials.gov
Benfotiamine in Diabetic Nephropathy
#152604
ClinicalTrials.gov
The Effects of Sevelamer Carbonate on Diabetic Nephropathy
#184777
ClinicalTrials.gov
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
#353407
ClinicalTrials.gov
DEL-1 and Thromboxane A2 in Diabetic Nephropathy Patients
#894312
ClinicalTrials.gov
Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy
#238259
ClinicalTrials.gov
T-regulatory Cells in Diabetic Type Two Nephropathy
#841677
ClinicalTrials.gov
Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children
#979245
ClinicalTrials.gov
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
#991893
ClinicalTrials.gov
Matrix Metalloproteinases and Diabetic Nephropathy
#261443
ClinicalTrials.gov
Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
#885177
ClinicalTrials.gov
Hyperuricemia and Diabetic Nephropathy
#287446
ClinicalTrials.gov
Hypomagnesemia and Diabetic Nephropathy
#865711
ClinicalTrials.gov
The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy
#287438
ClinicalTrials.gov
Treatment of Diabetic Nephropathy
#865697
ClinicalTrials.gov
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
#802674
ClinicalTrials.gov
Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?
#121298
ClinicalTrials.gov
Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy
#191578
ClinicalTrials.gov
Effect of Pyridorin in Patients With Diabetic Nephropathy
#804418
ClinicalTrials.gov
Effect of Sulodexide in Early Diabetic Nephropathy
#894871
ClinicalTrials.gov
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
#863718
ClinicalTrials.gov
Vitamin D Supplementation in Diabetic Nephropathy
#891599
ClinicalTrials.gov
Effect of Turmeric on Diabetic Nephropathy
#902788
ClinicalTrials.gov
ARIA (Atacand Renoprotection In NephropAthy Pt.)
#67722
ClinicalTrials.gov
Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy
#804559
ClinicalTrials.gov
Minocycline and Proteinuria in Diabetic Nephropathy
#845302
ClinicalTrials.gov
Atrasentan in Patients With Proteinuric Glomerular Diseases
#847953
ClinicalTrials.gov
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
#261452
ClinicalTrials.gov
Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
#136250
ClinicalTrials.gov
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
#369944
ClinicalTrials.gov
Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value
#830231
ClinicalTrials.gov
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
#892102
ClinicalTrials.gov
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
#857349
ClinicalTrials.gov
Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy
#897447
ClinicalTrials.gov
Pain Neuroscience Education in Diabetic Neuropathy
#683051
ClinicalTrials.gov
TCF7L2 Gene Polymorphism and AGEs in Diabetic Nephropathy
#848293
ClinicalTrials.gov
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
#226196
ClinicalTrials.gov
Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
#828853
ClinicalTrials.gov
Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)
#234559
ClinicalTrials.gov
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
#867083
ClinicalTrials.gov
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy
#889930
ClinicalTrials.gov
Nitric Oxide (NO) Activity and Diabetic Nephropathy
#175019
ClinicalTrials.gov
PeRsOnalising Treatment Of Diabetic Nephropathy:
#300379
ClinicalTrials.gov
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
#917719
ClinicalTrials.gov
Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
#160268
ClinicalTrials.gov
Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
#813928
ClinicalTrials.gov
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
#902307
ClinicalTrials.gov
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
#803436
ClinicalTrials.gov
Screening for Fabry Disease in Renal Transplantation
#853964
ClinicalTrials.gov
Transformative Research in Diabetic Nephropathy
#910539
ClinicalTrials.gov
Page 1 of 3
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.